Insider Trading Alert - NKE, ROSE And MMS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, April 2, 2014, 123 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $278.57 to $71,423,275.14.

Highlighted Stocks Traded by Insiders:

Nike (NKE) - FREE Research Report

Lechleiter John C who is Director at Nike bought 750 shares at $74.33 on April 2, 2014. Following this transaction, the Director owned 7,500 shares meaning that the stake was reduced by 11.11% with the 750-share transaction.

The shares most recently traded at $74.25, down $0.08, or 0.1% since the insider transaction. Historical insider transactions for Nike go as follows:

  • 4-Week # shares sold: 5,671
  • 12-Week # shares sold: 5,671
  • 24-Week # shares bought: 750
  • 24-Week # shares sold: 29,943

The average volume for Nike has been 4.0 million shares per day over the past 30 days. Nike has a market cap of $52.6 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are down 5.21% year-to-date as of the close of trading on Wednesday.

NIKE, Inc., together with its subsidiaries, engages in the design, development, marketing, and sale of athletic footwear, apparel, equipment, and accessories, as well as in the provision of services to men, women, and kids worldwide. The stock currently has a dividend yield of 1.21%. The company has a P/E ratio of 27.1. Currently there are 10 analysts that rate Nike a buy, no analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NKE - FREE

TheStreet Quant Ratings rates Nike as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Nike Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Rosetta Resources (ROSE) - FREE Research Report

Craddock James E who is Chairman, CEO & President at Rosetta Resources sold 3,000 shares at $46.64 on April 2, 2014. Following this transaction, the Chairman, CEO & President owned 129,705 shares meaning that the stake was reduced by 2.26% with the 3,000-share transaction.

The shares most recently traded at $49.79, up $3.15, or 6.33% since the insider transaction. Historical insider transactions for Rosetta Resources go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 9,000
  • 24-Week # shares sold: 18,000

The average volume for Rosetta Resources has been 1.2 million shares per day over the past 30 days. Rosetta Resources has a market cap of $2.9 billion and is part of the basic materials sector and energy industry. Shares are up 1.67% year-to-date as of the close of trading on Wednesday.

Rosetta Resources Inc., an independent exploration and production company, is engaged in the acquisition and development of onshore energy resources in the United States. The company has a P/E ratio of 13.8. Currently there are 9 analysts that rate Rosetta Resources a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ROSE - FREE

TheStreet Quant Ratings rates Rosetta Resources as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Rosetta Resources Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Maximus (MMS) - FREE Research Report

Beliveau Russell A who is Director at Maximus sold 1,000 shares at $44.92 on April 2, 2014. Following this transaction, the Director owned 63,179 shares meaning that the stake was reduced by 1.56% with the 1,000-share transaction.

Piloti Akbar who is Persident - Human Services at Maximus sold 3,290 shares at $45.00 on April 2, 2014. Following this transaction, the Persident - Human Services owned 13,878 shares meaning that the stake was reduced by 19.16% with the 3,290-share transaction.

The shares most recently traded at $44.58, down $0.42, or 0.94% since the insider transaction. Historical insider transactions for Maximus go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 180,190
  • 24-Week # shares sold: 196,096

The average volume for Maximus has been 439,700 shares per day over the past 30 days. Maximus has a market cap of $3.1 billion and is part of the services sector and diversified services industry. Shares are up 1.84% year-to-date as of the close of trading on Wednesday.

MAXIMUS, Inc. provides business process services to government health and human services agencies in the United States, Australia, Canada, the United Kingdom, and Saudi Arabia. The company operates in two segments, Health Services and Human Services. The stock currently has a dividend yield of 0.39%. The company has a P/E ratio of 25.1. Currently there are 4 analysts that rate Maximus a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MMS - FREE

TheStreet Quant Ratings rates Maximus as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Maximus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%